Because mesterolone is not 17α-alkylated, it has little or no potential for hepatotoxicity, although its risk of deleterious effects on the cardiovascular system is comparable to those of several other oral AAS.
However, its risk of deleterious effects on the cardiovascular system is comparable to that of several other oral AAS. Because mesterolone is not 17α-alkylated, it has little or no potential for hepatotoxicity.
Because mesterolone is not 17α-alkylated, it has little or no potential for hepatotoxicity. However, its risk of deleterious effects on the cardiovascular system is comparable to that of several other oral AAS.
Because mesterolone is not 17α-alkylated, it has little or no potential for hepatotoxicity. However, its risk of deleterious effects on the cardiovascular system is comparable to that of several other oral AAS.